4180248/2025-AQ.CENTRAL-A23151-ABEMACICLIB 50MG COATED TABLETS
About This Opportunity
TranslatedThis tender, identified by reference number 4180248/2025-AQ.CENTRAL-A23151, pertains to the acquisition of Abemaciclib 50mg coated tablets. The specific product code or internal reference is A23151, indicating a particular formulation or batch. The designation 'AQ.CENTRAL' likely refers to the central acquisition or procurement department responsible for this tender, possibly within a healthcare or pharmaceutical organization. The 'COMP REVES' part of the title translates to 'coated tablets', specifying the dosage form of the medication. Abemaciclib is a targeted therapy drug used primarily in the treatment of certain types of breast cancer, specifically hormone receptor-positive, HER2-negative advanced or metastatic breast cancer. The tender is seeking to procure a supply of this important pharmaceutical product. Further details regarding the quantity required, delivery timelines, specific quality standards, and eligibility criteria for bidders would typically be found in the full tender documentation. This procurement is crucial for ensuring the availability of advanced cancer treatments for patients. The tender process will likely involve a competitive bidding procedure, where qualified pharmaceutical suppliers will be invited to submit their proposals. The focus will be on ensuring a reliable supply chain for this critical medication, adhering to all regulatory and quality requirements.
This is a supplies contract in the trade and industry, health and medical services and Monitoring Evaluation sectors, with a focus on Pharmaceuticals and Manufacturing. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 10,523.
Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the trade and industry sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: PortugueseThis tender, identified by reference 4180248/2025-AQ.CENTRAL-A23151-ABEMACICLIB 50MG COMP REVES, is being issued by a contracting authority within Portugal. The procurement process is managed through the Portal BASE, which serves as the central platform for public contracts awarded in mainland Portugal and its autonomous regions. The specific focus of this tender is the acquisition of Abemaciclib 50mg capsules.
This is a pharmaceutical procurement, seeking to secure a supply of a specific medication. Typical requirements for tenders of this nature include detailed specifications for the pharmaceutical product, such as its active pharmaceutical ingredient (API) concentration, dosage form, and packaging. Suppliers are generally expected to demonstrate compliance with stringent quality standards, including Good Manufacturing Practices (GMP), and provide relevant regulatory approvals or certifications. Evidence of prior experience in supplying similar pharmaceutical products, particularly within public healthcare systems, is often a key evaluation criterion. Furthermore, bidders will likely be required to outline their proposed delivery timelines, supply chain robustness, and after-sales support capabilities. The tender will involve a competitive bidding process where economic and technical proposals will be evaluated to determine the most advantageous offer for the contracting authority.
Data provenance
This notice is sourced from base_gov_pt and was originally published on March 10, 2026. Last refreshed 4 days ago. Original language: Portuguese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Unidade Local de Saúde do Arco Ribeirinho, EPE
Unidade Local de Saúde do Arco Ribeirinho, EPE has issued 360 procurement notices on BidsFactory, including 0 currently open and 333 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Governance & Public Administration. All notices are published for Portugal. Notices are distributed via base_gov_pt and TED - Tenders Electronic Daily (EU). Most recent publication: June 18, 2026.
Frequently asked questions about this tender
How can I submit a bid?
Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to LILLY FARMA, LDA. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Unidade Local de Saúde do Arco Ribeirinho, EPE in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Industry & Manufacturing sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is Up to €10,523. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Where will the contract be performed?
The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.